Latest article
Metavention Declares Initiation of U.S. Scientific Trial for Novel Remedy of Sort 2 Diabetes
MINNEAPOLIS, February 17, 2021 / PRNewswire / - Metavention, Inc. announces the initiation of an FDA-cleared clinical investigation, DeLIVER (NCT04285554), for the company's iRF...
Teenagers With Weight problems Threat Coronary heart Assault, Diabetes As Adults
July 1, 2021 - Teenagers with obesity between the ages of 30 and 40 are more likely to have had a heart attack, type...
